Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial
- Publisher
- LANCET ONCOLOGY
- Language
- 영어
- ISSN
- 1470-2045
- Citation Volume
- 21
- Citation Number
- 6
- Citation Start Page
- 763
- Citation End Page
- 775
- 파일 목록
-
-
관련 파일이 존재하지 않습니다.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.